Evidence map›Paper›PMID 32105648›Full record

ReviewTranslational research : the journal of laboratory and clinical medicine2020

Structural approaches to pathway-specific antimicrobial agents.

Michael E Johnson, Leslie W-M Fung

Abstract readReview
In one paragraph

Review in Translational research : the journal of laboratory and clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michael E JohnsonDepartment of Pharmaceutical Sciences, Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, Illinois. Electronic address: mjohnson@uic.edu.
Leslie W-M FungDepartment of Chemistry, University of Illinois at Chicago, Chicago, Illinois. Electronic address: lfung@uic.edu.

Funding

Antibiotic Potentiation by Targeting of a Signal Transduction SystemR33AI111760 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI DAUM, ROBERT S. · 2016 to 2018
$1.5M
NIAID NIH HHS R33 AI111760
6 · The paper itself

Abstract

This perspective provides an overview of the evolution of antibiotic discovery from a largely phenotypic-based effort, through an intensive structure-based design focus, to a more holistic approach today. The current focus on antibiotic development incorporates assay and discovery conditions that replicate the host environment as much as feasible. They also incorporate several strategies, including target identification and validation within the whole cell environment, a variety of target deconvolution methods, and continued refinement of structure-based design approaches.

Indexed as

Drug DiscoveryAnti-Bacterial AgentsBiofilmsDrug DesignDrug DevelopmentDrug Therapy, CombinationGenomicsMetabolomicsAnti-Bacterial Agents

Identifiers

PMID32105648
PMCPMC7293926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.